VSTM CIK: 1526119

Verastem, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.11
FY22:
0.09
FY23:
0.14
FY24:
0.09
FY25:
0.22
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.00
FY22:
0.00
FY23:
0.01
FY24:
0.01
FY25:
0.02
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.11
FY22:
0.10
FY23:
0.15
FY24:
0.10
FY25:
0.25

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.02
FY22:
0.02
FY23:
0.03
FY24:
0.03
FY25:
0.07
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.00
FY22:
0.03
FY23:
0.04
FY24:
0.10
FY25:
0.12
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.09
FY22:
0.05
FY23:
0.06
FY24:
−0.03
FY25:
0.06
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.11
FY22:
0.10
FY23:
–
FY24:
0.10
FY25:
0.25

All amounts in billions USD Data source:SEC EDGAR